CD47 and cancer: The antiphagocytic function of CD47 contributes to the association of poor survival with higher CD47 expression in some cancers [3,4,5,6], but we cannot exclude that coregulation of IFT57 also contributes to the survival deficits in tumors with high CD47 expression.